How does labetalol affect the management of hypertension in patients with autoimmune diseases and what are the potential challenges?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer peopleβs questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Labetalol, a beta-blocker with alpha-blocking activity, can effectively manage hypertension in autoimmune patients by reducing arterial pressure. However, it may mask hypoglycemia symptoms or exacerbate Raynaud’s phenomenon, complicating management in those with conditions like diabetes or scleroderma.